The novel autophagy inhibitor ROC-325 augments the anti-leukemic activity of azacitidine

Lignende værker

• Disruption of autophagic degradation with ROC-325 antagonizes renal cell carcinoma pathogenesis
  af: Carew, Jennifer S., et al.
  Udgivet: (2016)
• Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine
  af: Visconte, Valeria, et al.
  Udgivet: (2015)
• Drain the lysosome: Development of the novel orally available autophagy inhibitor ROC-325
  af: Carew, Jennifer S., et al.
  Udgivet: (2017)
• Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms
  af: Visconte, Valeria, et al.
  Udgivet: (2016)
• Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
  af: Jones, Trace M., et al.
  Udgivet: (2019)